ScholarLens Back to search
2013•Journal watchRequires access

Control of Genital Warts Is Within Reach . . . but Not in the U.S.

Anna Wald

Open publisher page 0 citations

Abstract

In clinical trials, the quadrivalent human papillomavirus (HPV) vaccine provides excellent protection against genital warts. Now, Australian investigators have shown high effectiveness of the vaccine in a nationwide program begun in 2007 that has led to routine, free vaccination of women aged …

About this research paper

What this paper is about

In clinical trials, the quadrivalent human papillomavirus (HPV) vaccine provides excellent protection against genital warts. Now, Australian investigators have shown high effectiveness of the vaccine in a nationwide program begun in 2007 that has led to routine, free vaccination of women aged …

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In clinical trials, the quadrivalent human papillomavirus (HPV) vaccine provides excellent protection against genital warts. Now, Australian investigators have shown high effectiveness of the vaccine in a nationwide program begun in 2007 that has led to routine, free vaccination of women aged …

Key concepts: Genital warts, Medicine, Human papillomavirus, Vaccination, Clinical trial, Sex organ, Virology, Dermatology

Back to paper searchBrowse research topicsOriginal source
Control of Genital Warts Is Within Reach . . . but Not in the U.S. — Research Paper | ScholarLens